TrivarX Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC

ASX:TRIHealthcare

Country Australia

PE (Fwd) •••

TSR 10Y CAGR (48.90%)

Div yield —

ROE (61.23%)

Health Information Services

Beta (5Y) 1.06

PE TTM —

TSR TTM (54.55%)

Mkt cap A$11.54M

ROIC (36.41%)

SE Grade™

—

Value

Quality

Moat

Consensus

Reference

$0.0128

27.70%

104.43%

Hold 3|3|1|11|0

TTM

FYE 30 Jun AUD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

5.601

Revenue$M

6.493

6.532

6.427

6.597

6.583

6.478

6.387

6.247

6.202

6.127

5.841

(1.43%)

(0.66%)

81

23.76

Revenue growth%

0.40

1.07

0.40

1.55

2.01

4.15

4.17

3.91

2.92

1.44

26.18

3.91

1.78

87

2.92

Gross margin%

16.92

16.49

15.44

15.84

15.19

17.36

18.46

18.45

16.17

14.16

8.23

17.36

16.33

63

17.52

Operating margin%

8.26

8.87

6.88

6.97

6.05

3.12

0.53

0.40

0.40

1.80

7.77

0.53

4.59

85

5.19

Net margin%

8.24

6.20

4.06

3.96

1.64

2.29

2.18

0.40

0.40

0.40

28.16

0.40

2.24

53

22.81

P/E ratio (avg)x

14.63

16.02

17.21

16.62

17.56

17.26

18.64

20.47

20.60

19.45

25.40

19.45

17.41

83

22.08

EV/EBITx

54.95

56.54

62.84

66.82

65.74

75.93

87.04

98.23

102.7

110.3

12.65

98.23

71.37

74

26.31

FCF yield (avg)%

8.83

6.16

7.43

5.71

5.90

4.70

3.74

1.29

1.36

4.21

16.77

3.74

5.20

73

27.74

FCF margin%

19.16

17.29

16.47

15.29

12.87

11.96

12.95

11.82

11.40

9.04

8.52

11.82

12.91

24

1.356

FCF / Net incomex

1.595

1.495

1.416

1.292

1.139

0.982

0.915

0.873

0.916

0.994

0.995

0.916

1.066

39

17.15

ROIC%

4.96

2.87

5.64

7.02

6.33

7.93

7.72

4.99

5.63

7.70

5.69

7.70

5.98

93

26.01

Return on equity%

10.99

8.96

7.32

8.51

6.88

6.07

3.76

3.82

5.17

6.31

21.72

5.17

6.59

28

18.12

Return on assets%

8.68

9.80

12.58

13.56

15.17

12.97

11.16

10.73

9.01

6.15

28.26

10.73

10.95

30

—

EPS$

—

—

—

—

—

—

—

—

—

—

—

(4.09%)

(3.03%)

—

4.57

EPS growth%

23.24

25.75

23.06

22.98

20.73

18.38

20.67

23.28

22.60

23.97

16.18

22.60

23.02

23

—

Bookvalue per sh$

—

—

—

—

—

—

—

—

—

—

—

0.14%

1.17%

—

—

FCF per share$

—

—

—

—

—

—

—

—

—

—

—

(3.46%)

(3.38%)

—

—

Dividend per sh$

—

—

—

—

—

—

—

—

—

—

—

6.52%

5.28%

—

3.99

Div yield (avg)%

20.95

21.09

23.60

21.69

19.79

20.52

20.87

18.96

20.42

20.02

16.16

20.42

20.70

54

15.79

Payout ratio%

21.99

23.91

25.03

25.04

22.23

21.60

23.71

23.38

22.21

25.15

10.32

23.38

23.54

55

1.179

Shares (diluted)B

1.194

1.164

1.193

1.175

1.244

1.321

1.278

1.211

1.321

1.292

1.121

0.76%

0.21%

56

3.16

Buyback yield%

20.46

21.77

19.78

17.37

15.60

12.79

10.19

8.24

6.68

9.34

13.98

9.34

14.20

21

0.331

D/E ratiox

0.340

0.295

0.273

0.255

0.266

0.273

0.254

0.225

0.210

0.182

0.156

0.225

0.260

80

3.450

Enterprise value$M

2.983

3.305

3.181

2.955

2.996

2.803

3.101

3.327

3.579

3.443

1.436

2.81%

1.30%

34

2.469

LT debt$M

4.047

3.666

3.993

4.171

4.228

4.074

4.342

4.497

4.175

3.884

2.378

(1.68%)

(0.50%)

61

Peers (US$7.924M)

Cap (US$)

PE

PainChek Limited

10.05M

—

Intelicare Holdings…

8.843M

—

TALi Digital Limited

7.385M

—

8.327M

—

Capital

TTM

5Y

10Y

Leveragex

0.652

0.140

0.129

EBIT/Intx

0.340

0.318

0.310

Own earn%

(44.46)

147.19

117.76

Sh yield%

7.15

29.36

34.35

Owners

Insiders/Inst%

10.06

67.17

Short interest%

3.08

SBC / revenue%

0.34

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

5

Op margin range%

0–9

$1 testx

—

Incr. ROIC%

−1

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$6.127M

(0.66%)

1.00×

Cost of revenue

$4.289M

(0.66%)

1.00×

Operating expenses

$1.200M

(0.48%)

1.02×